IDEX Corp
IEX: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$819.00 | Scpl | Bdvjtppkw |
Idex Earnings: Full-Year Outlook Maintained After Solid First Quarter
Narrow-moat-rated Idex posted solid first-quarter results, considering headwinds in the life sciences and analytical instrumentation businesses, as its adjusted EPS of $1.88 came in above management’s guidance range of $1.70 to $1.75. While nothing in the earnings release materially alters our long-term outlook, we’ve sightly raised our fair value estimate to $220 from $219 due to time value of money. We view the name as fairly valued at current levels.